Australia's largest stock trading and investment forum Australia's #1 stock forum

ALT

0.00%

0.1¢ analytica limited

setting sales goal, page-12

First 12 Last

Share
Profile

Follow
oscarone

6,725 Posts.

14

11/07/14

13:42

Post #: 13646000
Share

Originally posted by Pubic Beast ↑

This has made me rethink the sales potential for Pericoach and whether or not it is worth the risk of buying into.
I spoke to my wife and her sister (both nurses with 30+ years experience each) about pelvic floor exercise and if they had heard of Pericoach. Neither had heard of Pericoach but both said they knew of other devices (and had instructed clients on their use) that were used in hospitals and clinics that did a similar thing but without the ability to send data to smartphones and then onto the urologist via PeriCloud. They could not see the need however to spend $300 on a product that did what they could do for free (and could not see most women forking out that amount of money). They felt that most young pregnant women are taught about pelvic floor exercise during pregnancy to help with urinary stress incontinence after birth anyway and may have probably used those other devices they knew of for free at the incontinence clinics. They themselves have never used these devices (both had four children) and got by with just doing the exercises (and yes they did have incontinence issues). They even said they did their exercises while hanging out the washing! They felt that only women who have developed severe stress incontinence problems due to trauma or giving birth to large babies might seek a urologist for guidance (and or surgery if required) and perhaps then use a monitoring device like the Pericoach. I have three daughters with seven children between them and none have used these devices but do the exercises. Just saying.

Expand

Well done for DYOR and in the end that's probably the number one thing to do at this end of the market.

And I am pretty sure most suffers will not use such a device.
I thought however the target market was those women whose problem was such that they sort out a clinician. ?
Where not the original figures touted based on 1% of the 15% who said they would use such a device?

I cant look it up atm so don't take my word for it.

Cheers

Oscar

ALT Price at posting: 3.9¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

AW1

American West does it again at Storm with visually identified thick copper hits at Cyclone, Lightning Ridge

PYC

PYC commences new study on drug for eye condition Retinitis Pigmentosa type 11

GRE

Greentech finds lithium trend across 5.5 km at WA's Kobe South

LGM

Legacy shares jump on discovery of multiple epithermal veins at Bauloora JV

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”